The frequency of CYP2C19 genetic polymorphisms in Russian patients with peptic ulcers treated with proton pump inhibitors

INTRODUCTION: Proton pump inhibitors, which are widely used as acid-inhibitory agents for the treatment of peptic ulcers, are mainly metabolized by 2C19 isoenzyme of cytochrome P450 (CYP2C19). CYP2C19 has genetic polymorphisms, associated with extensive, poor, intermediate or ultra-rapid metabolism...

Descripción completa

Detalles Bibliográficos
Autores principales: Sychev, DA, Denisenko, NP, Sizova, ZM, Grachev, AV, Velikolug, KA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4472152/
https://www.ncbi.nlm.nih.gov/pubmed/26109874
http://dx.doi.org/10.2147/PGPM.S78986

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4472152/
https://www.ncbi.nlm.nih.gov/pubmed/26109874
http://dx.doi.org/10.2147/PGPM.S78986

Ejemplares similares